USA Pharma News | Healthcare News

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

AstraZeneca's ADC Enhertu is now approved in US for HR-positive, HER2-low or ultra low breast cancer | iPharmaCenter

ipharmaservices

Feb 3

0

BeiGene's PD-L1 inhibitor Tevimbra approved in the US for advanced gastric or gastroesophageal junction (G/GEJ) cancers | iPharmaCenter

ipharmaservices

Jan 3

0

FDA Devices Approval | 2024 | Abbott News | iPharmaCenter

FDA Devices Approval | 2024 | Abbott News | iPharmaCenter

ipharmaservices

Apr 3, 2024

0

FDA Diagnostics Approvals | 2024 | FDA Approvals | iPharmaCenter

FDA Diagnostics Approvals | 2024 | FDA Approvals | iPharmaCenter

ipharmaservices

Mar 28, 2024

0

Centers for Disease Control and Prevention | CDC | iPharmaCenter | 2024

Centers for Disease Control and Prevention | CDC | iPharmaCenter | 2024

ipharmaservices

Mar 4, 2024

0

Express-Scripts | Pharmacy Benefit Manager | News | Updates | 2024 | US Healthcare | iPharmaCenter

Express-Scripts | Pharmacy Benefit Manager | News | Updates | 2024 | US Healthcare | iPharmaCenter

ipharmaservices

Feb 14, 2024

0

Eisai's Leqembi received FDA approval for Alzheimer's | CMS coverage of Leqembi | ipharmacenter

Eisai's Leqembi received FDA approval for Alzheimer's | CMS coverage of Leqembi | ipharmacenter

ipharmaservices

Jan 10, 2023

0

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Oct 9, 2022

0

Genzyme's Xenpozyme approved for Acid Sphingomyelinase Deficiency | iPharmaCenter

Genzyme's Xenpozyme approved for Acid Sphingomyelinase Deficiency | iPharmaCenter

ipharmaservices

Sep 1, 2022

0

Lilly's and Incyte's Olumiant approved for adults with severe alopecia areata

Lilly's and Incyte's Olumiant approved for adults with severe alopecia areata

ipharmaservices

Jun 16, 2022

0

Myasthenia Gravis News | FDA and EMA approvals |

Myasthenia Gravis News | FDA and EMA approvals |

ipharmaservices

Dec 22, 2021

0

American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates

American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates

ipharmaservices

Nov 10, 2021

0

FDA approved Novartis Scembli for chronic myeloid leukemia

FDA approved Novartis Scembli for chronic myeloid leukemia

ipharmaservices

Nov 2, 2021

0

Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval

Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval

ipharmaservices

Jun 8, 2021

0

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

ipharmaservices

Apr 23, 2021

0

BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma

ipharmaservices

Mar 28, 2021

0

Novartis’ blockbuster Entresto received the US FDA approval for a broader target population

ipharmaservices

Feb 21, 2021

0

US FDA approved BMS gene therapy Breyanzi

US FDA approved BMS gene therapy Breyanzi

ipharmaservices

Feb 8, 2021

0

Merck and Bayer announced the US FDA approval for Verquvo

ipharmaservices

Jan 21, 2021

0

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

bottom of page